In just over 12 months of launching, Alflorex® has been awarded Best Irish Pharmacy Product in IPN Awards 2015. Alflorex is a new PrecisionBiotic™ which contains the unique and patented strain B. infantis 35624. With up to 30% of the population suffering from digestive health issues such as excess wind, cramping, bloating, constipation and diarrhoea, Alflorex is an important new supplement available over-the-counter.
- infantis 35624, or BIFORTIF™, has been clinically studied in IBS patients1,2 and shown to reduce abdominal discomfort, bloating and passage of gas. Discovered by Irish company Alimentary Health, Alflorex is backed by more than 15 years of clinical research and 50 leading scientific publications.
According to Professor Eamonn Quigley, one of the early investigators and Chief of Division of Gastroenterology, Houston Methodist Hospital:
“The gut bacteria plays an important role in many digestive health issues. B. infantis 35624, the strain in Alflorex, is one of the few products which has been truly developed on a scientific basis and tested in high quality clinical studies.”
Speaking about the award Dr Barry Kiely, CEO of Alimentary Health said:
“Anyone suffering from digestive health issues will know the discomfort and misery that these problems bring to day-to day-living. Since launching in Ireland, we have received an enormous response from consumers. Alflorex is changing their lives which is similar to the response we have had in North America where B. infantis 35624 is the No. 1 Gastroenterologist recommended strain. We are delighted to receive this award. A huge amount of research and effort has gone into developing Alflorex and we are delighted to get such a strong endorsement from Irish pharmacists.”